Washington must lead search for additional financing, more cost-effective strategies in fight against AIDS

This New York Times editorial responds to the latest UNAIDS report (.pdf), which it says "reveals substantial success by some measures and stagnation by others," writing, "The challenge, in tough times, that must be met is to find enough resources to capitalize on scientific breakthroughs and keep the campaign moving forward."

The editorial states that prevention and treatment strategies outlined in a speech by Secretary of State Hillary Clinton last month "are the only way to get ahead of the epidemic. But the global economic downturn led to a collective decline in donor assistance last year." It concludes, "Washington has led the effort to combat AIDS and will need to lead the search for additional donor contributions, greater financing by AIDS-afflicted nations that can afford it, and more cost-effective approaches to prevention and treatment. This is no time to lose ground against a scourge that, while no longer always fatal, is still infecting people faster than they can be tested and treated" (11/27).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Semaglutide improves heart health and reduces weight in obese patients, but with side effects